Condition
Invasive Breast Cancer Early Stages
Total Trials
2
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Venus Shell Immobilization Device
Research Leaders
5 sponsors active, led by University Hospital, Geneva
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Clinical Trials (2)
Research Network
Common Treatments
- Venus Shell Immobilization Device1
Active Sponsors
- University Hospital, Geneva1
- HeroSupport SA1
- AECC_Asociación Española contra el Cáncer1
- MDSS1
- Spanish Breast Cancer Research Group1
Top Investigators
NYU Langone Health
Related Conditions
- Patients With Invasive Breast Cancer In Early Stages1
- Ductal Carcinoma In Situ Dcis1